We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.33B
1-Year Est. Return 18.98%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
Cap. Flow
+$135M
Cap. Flow %
6.32%
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.04M
2
CVS icon
CVS Health
CVS
+$650K
3
CIVB icon
Civista Bancshares
CIVB
+$555K
4
MMM icon
3M
MMM
+$392K
5
UL icon
Unilever
UL
+$357K

Sector Composition

Rank Sector Weight
1 Technology 7.84%
2 Financials 7.12%
3 Consumer Staples 1.93%
4 Healthcare 1.77%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
101
UnitedHealth
UNH
$389B
$1.25M 0.06%
2,447
-19
-0.8% -$9.31K
MDT icon
102
Medtronic
MDT
$111B
$1.24M 0.06%
15,773
+95
+0.6% +$7.79K
PFE icon
103
Pfizer
PFE
$144B
$1.24M 0.06%
44,230
+2,730
+7% +$75.2K
SHEL icon
104
Shell
SHEL
$238B
$1.21M 0.06%
16,772
+241
+1% +$17.2K
BAC icon
105
Bank of America
BAC
$439B
$1.19M 0.06%
29,908
-513
-2% -$19.7K
ABT icon
106
Abbott
ABT
$187B
$1.19M 0.06%
11,407
-140
-1% -$14.8K
PYPL icon
107
PayPal
PYPL
$50.3B
$1.17M 0.05%
20,190
+4,006
+25% +$255K
WMB icon
108
Williams Companies
WMB
$85.8B
$1.17M 0.05%
27,526
-6,015
-18% -$241K
TPL icon
109
Texas Pacific Land
TPL
$26.9B
$1.17M 0.05%
4,770
-540
-10% -$113K
FNDB icon
110
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.43B
$1.17M 0.05%
53,385
+777
+1% +$16.8K
PNC icon
111
PNC Financial Services
PNC
$100B
$1.14M 0.05%
7,356
-24
-0.3% -$3.72K
KVUE icon
112
Kenvue
KVUE
$37.9B
$1.1M 0.05%
60,730
+9,872
+19% +$191K
ORCL icon
113
Oracle
ORCL
$346B
$1.1M 0.05%
7,783
+1,186
+18% +$147K
MCK icon
114
McKesson
MCK
$104B
$1.09M 0.05%
1,865
+2
+0.1% +$1.11K
USB icon
115
US Bancorp
USB
$100B
$1.07M 0.05%
26,886
+6
+0% +$245
NVS icon
116
Novartis
NVS
$304B
$1.05M 0.05%
9,881
-40
-0.4% -$4.01K
VV icon
117
Vanguard Large-Cap ETF
VV
$52B
$1.05M 0.05%
4,207
DIS icon
118
Walt Disney
DIS
$172B
$1.04M 0.05%
10,492
-26
-0.2% -$2.8K
INGR icon
119
Ingredion
INGR
$6.48B
$1.04M 0.05%
9,055
-10
-0.1% -$1.16K
HON icon
120
Honeywell
HON
$78.3B
$1.03M 0.05%
5,101
-11
-0.2% -$2.09K
TRV icon
121
Travelers Companies
TRV
$82.9B
$1.01M 0.05%
4,949
-126
-2% -$27.1K
HIG icon
122
Hartford Financial Services
HIG
$39.3B
$1M 0.05%
9,983
+1
+0% +$100
DFAT icon
123
Dimensional US Targeted Value ETF
DFAT
$14.8B
$995K 0.05%
19,180
BA icon
124
Boeing
BA
$175B
$975K 0.05%
5,355
+1,500
+39% +$267K
AFL icon
125
Aflac
AFL
$65.9B
$952K 0.04%
10,665
-828
-7% -$71.2K

Similar funds

Nicholas Hoffman & Company's Q2 2024 Portfolio in Review

As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.

  • Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
  • Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
  • Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
  • Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
  • Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
  • Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
  • Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.